Perspective Therapeutics, Inc.
CATX· NYSE
CATXPerspective Therapeutics, Inc.
Filed Nov 14, 2012 · 10-Q · 45 days after period end · 0001144204-12-062486
| Metric | Q1 2013 | Q1 2012 | Q1 2011 |
|---|---|---|---|
| Revenue | $1.06M | $1.21M | $1.33M |
| Net Income | -$993.67K | -$1.10M | -$871.88K |
| EPS Diluted | -$0.03 | -$0.04 | -$0.04 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Perspective Therapeutics, Inc. · CIK 728387 · Engraved from SEC EDGAR
ended Sep 30, 2012 · filed Nov 14, 2012 · 45 d after period end
